Back to MORGAN STANLEY MORGAN STANLEY

MBXMBX
7 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in MBX Biosciences, Inc.

MORGAN STANLEY holds 248,558 shares of MBX (MBX Biosciences, Inc.), worth $13.7M as of 2026-Q2. The position was increased (+687.5% shares). MBX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$13.7M

Current Shares

248,558

Total Value Change

+$13.3M

Total Shares Change

+224,723

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
248,558
+687.5%
$13.7M0.0%$55.20
45
2026-Q1
Decreased
31,562
-46.5%
$942,1260.0%$30.54
0
2025-Q4
Increased
59,026
+31.6%
$1.9M0.0%$30.90
33
2025-Q3
Increased
44,868
+86.9%
$785,1910.0%$17.94
26
2025-Q2
Decreased
24,008
-79.0%
$273,9310.0%$10.75
0
2025-Q1
Increased
114,610
+380.9%
$845,8210.0%$7.76
40
2024-Q4
New
23,835
-
$439,2790.0%$17.91
37

Other major holders of MBX: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used